Prosecution Insights
Last updated: October 04, 2026

National University Corporation Saitama University

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

National University Corporation Saitama University is currently navigating 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 3 pending office actions indicate the level of patent procurement for the institution. The prosecution involves 2 distinct examiners, which requires the university to manage different sets of examiner expectations. With 2 distinct examiners, the portfolio's progress is subject to multiple examination styles.

All active matters are concentrated within 1 distinct art unit. This focus on 1 distinct art unit suggests the technical focus for the university's current biotechnology and pharmaceutical filings. SPEED, DEQUANTARIUS JAVON is the busiest examiner for this portfolio, currently handling 2 pending office actions. Because SPEED, DEQUANTARIUS JAVON manages the 2 pending office actions, this examiner has an influence on the overall progress of the university's pending applications. The fact that the busiest examiner oversees multiple matters means that the institution's success in this technology area is tied to the determinations of this specific official.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
2
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (67%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SPEED, DEQUANTARIUS JAVON 2 70.0% +69.2%
ROSENAU, DEREK JOHN 1 77.7% +8.0%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18164700 MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SPEED, DEQUANTARIUS JAVON 56d
18165026 MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SPEED, DEQUANTARIUS JAVON 56d
18590487 ROTATING APPARATUS, MOTOR, AND PUMP ROSENAU, DEREK JOHN —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18164700 MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SPEED, DEQUANTARIUS JAVON 56d
18165026 MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SPEED, DEQUANTARIUS JAVON 56d

Top Art Units

Art UnitApps
1663 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18590487 ROTATING APPARATUS, MOTOR, AND PUMP ROSENAU, DEREK JOHN — §102§103 Non-Final OA — Pending Feb 28, 2024
18164700 MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SPEED, DEQUANTARIUS JAVON 1663 §101§112Other Final Rejection 56d Pending Feb 06, 2023
18165026 MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SPEED, DEQUANTARIUS JAVON 1663 §101§112Other Final Rejection 56d Pending Feb 06, 2023

Managing National University Corporation Saitama University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month